ONCOLYTICS BIOTECH INC (ONCY) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
ONCY currently has 116M outstanding shares. with minimal authorized share overhang for future dilution. The company has significantly diluted shareholders by 52.64% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Apr 01, 2026 |
POS AM filing: This Post-Effective Amendment No. 1 relates to the Registration Statement on Form F-3 pertaining to the registration of offers and sales by the Company of common shares, subscription receipts, warrants and units and the Company hereby withdraws this Registration Statement, including all amendments and exhibits thereto, with respect to the unsold portion of securities registered hereon. |
120M | 0 |
| Apr 01, 2026 |
S-3 filing: Oncolytics Biotech Inc. may offer and sell up to $250,000,000 in the aggregate of common stock, preferred stock, warrants, purchase contracts, and units from time to time in one or more offerings. |
120M | 0 |
| Mar 30, 2026 |
10-K filing | 116.1M shares outstanding |
120M | 65M |
| Aug 22, 2025 |
F-3 filing: Oncolytics Biotech Inc. may offer and sell up to US$150,000,000 in the aggregate of its common shares, subscription receipts exchangeable for common shares and/or other securities, warrants exercisable to acquire common shares and/or other securities and securities comprised of more than one of common shares, subscription receipts and/or warrants offered together as a unit, or any combination thereof, from time to time in one or more offerings. |
80M | 100M |
| Mar 07, 2025 |
20-F filing | 80.0M shares outstanding |
80M | 0 |
| Jul 25, 2024 |
F-10 filing: This is an F-10 filing which describes the terms for offering common shares, subscription receipts, warrants and/or units. |
74M | 0 |
| Mar 12, 2024 |
20-F filing | 74.4M shares outstanding |
74M | 0 |
| Mar 03, 2023 |
20-F filing | 61.3M shares outstanding |
61M | 0 |
| Mar 03, 2022 |
20-F filing | 55.0M shares outstanding |
55M | 0 |
| Mar 05, 2021 |
20-F filing | 46.2M shares outstanding |
46M | 0 |
| Jun 08, 2020 |
F-10 filing: The filing is for an F-10 form which is a prospectus for a Canadian issuer using the MJDS system to offer various securities including Common Shares, Subscription Receipts, Warrants and Units. The specific terms will be in a Prospectus Supplement. |
32M | 0 |
| Mar 06, 2020 |
20-F filing | 32.2M shares outstanding |
32M | 0 |